LEUKEMIA, LYMPHOCYTIC, ACUTE
Clinical trials for LEUKEMIA, LYMPHOCYTIC, ACUTE explained in plain language.
Never miss a new study
Get alerted when new LEUKEMIA, LYMPHOCYTIC, ACUTE trials appear
Sign up with your email to follow new studies for LEUKEMIA, LYMPHOCYTIC, ACUTE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Scientists train immune cells to hunt down mutated blood cancers
Disease control Recruiting nowThis early-phase trial tests a personalized treatment for people with blood cancers like leukemia. Doctors take a patient's own T cells, modify them in the lab to recognize unique cancer mutations, and infuse them back after a short course of chemotherapy. The goal is to see if t…
Matched conditions: LEUKEMIA, LYMPHOCYTIC, ACUTE
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jul 02, 2026 02:00 UTC
-
New hope for Hard-to-Treat leukemia? enzomenib trial launches
Disease control Recruiting nowThis study tests a new oral drug called enzomenib (DSP-5336) in people with acute leukemia and certain other blood cancers that have not responded to standard treatments. The trial has two phases: first, finding the safest dose, and then checking how well it works alone or combin…
Matched conditions: LEUKEMIA, LYMPHOCYTIC, ACUTE
Phase: PHASE1, PHASE2 • Sponsor: Sumitomo Pharma America, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC